Literature DB >> 2307730

Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism.

M S Lee1, S Y Kim, M C Lee, B Y Cho, H K Lee, C S Koh, H K Min.   

Abstract

To assess the changes in bone mineral density and osteoblastic activity in patients with hyperthyroidism and to investigate the relationship between those changes, we measured bone mineral density and serum osteocalcin in 109 patients with Graves' disease, comprising 75 untreated patients and 34 patients under treatment, and 200 normal controls. The degree of change in bone mineral density was quantified with Z transformation, in which we used means and SDs of bone mineral densities obtained in the process of age- and sex-matched 1:1 pairing developed by ourselves. Bone mineral density was low in female patients with hyperthyroidism in the spine, femur neck, trochanter, and Ward's triangle, but was not low in male patients. Serum osteocalcin was elevated in patients with untreated Graves' disease and correlated negatively with the Z values of bone mineral densities of the spine, femur neck, and trochanter. In conclusion, indices of osteoblastic activity were elevated in patients with hyperthyroidism, probably secondary to a thyroid hormone-induced increase in bone resorption which resulted in reduced bone mineral density. Quantification of the change in bone mineral density by using the parameters derived in the process of age- and sex-matched pairing seems to be an efficient method for statistical analyses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307730     DOI: 10.1210/jcem-70-3-766

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Spontaneous release of interleukin 1 beta from human blood monocytes in thyrotoxic osteodystrophy.

Authors:  D Bisbocci; V Gallo; P Damiano; L Sidoli; R Cantoni; G Aimo; G Priolo; R Pagni; L Chiandussi
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

2.  Bone turnover in hyperthyroidism before and after thyrostatic management.

Authors:  G C Isaia; C Roggia; D Gola; M D Stefano; G Gallone; G Aimo; P Ardissone; M Mussetta
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

3.  Acute and early effects of triiodothyronine administration on serum markers of bone and mineral metabolism.

Authors:  N Kobe; J Takamatsu; M Ito; S Sakane; N Ohsawa
Journal:  Endocrine       Date:  1999-02       Impact factor: 3.633

4.  Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease.

Authors:  T Majima; Y Komatsu; K Doi; C Takagi; M Shigemoto; A Fukao; T Morimoto; J Corners; K Nakao
Journal:  Osteoporos Int       Date:  2006-04-07       Impact factor: 4.507

5.  Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?

Authors:  Tina Z Belsing; Charlotte Tofteng; Bente L Langdahl; Peder Charles; Ulla Feldt-Rasmussen
Journal:  Nutr Metab (Lond)       Date:  2010-09-01       Impact factor: 4.169

6.  Increased rat femur osteocalcin mRNA concentrations following in vivo administration of thyroid hormone.

Authors:  D S Ross; R Graichen
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

7.  Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.

Authors:  N Kojima; S Sakata; S Nakamura; K Nagai; H Takuno; T Ogawa; I Matsui; H Sarui; K Miura
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

8.  Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children.

Authors:  G Weber; S Mora; A Bellini; M Bosco; C Prinster; V Siragusa; B di Natale; G Chiumello
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

9.  Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men.

Authors:  El Hadidy M El Hadidy; Mohamed Ghonaim; Soma Sh Abd El Gawad; Mohamed Abou El Atta
Journal:  BMC Endocr Disord       Date:  2011-08-06       Impact factor: 2.763

Review 10.  Bone disease in thyrotoxicosis.

Authors:  P Amaresh Reddy; C V Harinarayan; Alok Sachan; V Suresh; G Rajagopal
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.